Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.
about
Characterization of different regimens for initiating anagrelide in patients with essential thrombocythemia who are intolerant or refractory to their current cytoreductive therapy: results from the multicenter FOX study of 177 patients in France.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Characterization of different ...... udy of 177 patients in France.
@ast
Characterization of different ...... udy of 177 patients in France.
@en
Characterization of different ...... udy of 177 patients in France.
@nl
type
label
Characterization of different ...... udy of 177 patients in France.
@ast
Characterization of different ...... udy of 177 patients in France.
@en
Characterization of different ...... udy of 177 patients in France.
@nl
prefLabel
Characterization of different ...... udy of 177 patients in France.
@ast
Characterization of different ...... udy of 177 patients in France.
@en
Characterization of different ...... udy of 177 patients in France.
@nl
P2093
P2860
P356
P1476
Characterization of different ...... udy of 177 patients in France.
@en
P2093
FOX study investigators
Jean-François Viallard
Jean-Jacques Kiladjian
Jonathan Smith
Jérôme Rey
Karim Keddad
Paul Wilde
P2860
P304
P356
10.1111/EJH.12210
P577
2013-11-25T00:00:00Z